Lee S-G
Hepato-Biliary Surgery and Liver Transplantation, Asan Medical Center, University of Ulsan College of Medicine, Ulsan University, Seoul, Republic of Korea.
Am J Transplant. 2015 Jan;15(1):17-38. doi: 10.1111/ajt.12907. Epub 2014 Oct 30.
The growing disparity between the number of liver transplant candidates and the supply of deceased donor organs has motivated the development of living donor liver transplantation (LDLT). Over the last two decades, the operation has been markedly improved by innovations rendering modern results comparable with those of deceased donor liver transplantation (DDLT). However, there remains room for further innovation, particularly in adult living donor liver transplantation (ALDLT). Unlike whole-size DDLT and pediatric LDLT, size-mismatching between ALDLT graft and recipient body weight and changing dynamics of posttransplant allograft regeneration have remained major challenges. A better understanding of the complex surgical anatomy and physiologic differences of ALDLT helps avoid small-for-size graft syndrome, graft congestion from outflow obstruction and graft hypoperfusion from portal flow steal. ALDLT for high-urgency patients (Model for End-Stage Liver Disease score >30) can achieve results comparable to DDLT in high volume centers. Size limitations of partial grafts and donor safety issues can be overcome with dual grafts and modified right-lobe grafts that preserve the donor's middle hepatic vein trunk. Extended application of LDLT for unresectable hepatocellular carcinoma above Milan criteria is an optional strategy at the cost of slightly compromised survival. ABO-blood group incompatibility obstacles have been broken down by introducing a paired donor exchange program and refined peri-operative management of ABO-incompatible ALDLT. This review focuses on recent innovations of surgical techniques, safe donor selection, current strategies to expand ALDLT with broadened patient selection criteria and important aspects of teamwork required for success.
肝移植候选者数量与已故供体器官供应之间日益扩大的差距推动了活体肝移植(LDLT)的发展。在过去二十年中,通过创新显著改善了该手术,使现代手术结果与已故供体肝移植(DDLT)相当。然而,仍有进一步创新的空间,特别是在成人活体肝移植(ALDLT)方面。与全尺寸DDLT和小儿LDLT不同,ALDLT移植物与受体体重之间的尺寸不匹配以及移植后同种异体移植物再生的动态变化仍然是主要挑战。更好地了解ALDLT复杂的手术解剖结构和生理差异有助于避免小体积移植物综合征、流出道梗阻导致的移植物充血以及门静脉血流窃血导致的移植物灌注不足。在高容量中心,为高紧急性患者(终末期肝病模型评分>30)进行的ALDLT可取得与DDLT相当的结果。部分移植物的尺寸限制和供体安全问题可通过双移植物和保留供体肝中静脉主干的改良右叶移植物来克服。将LDLT扩展应用于超过米兰标准的不可切除肝细胞癌是一种可选策略,但以生存率略有降低为代价。通过引入配对供体交换计划和完善ABO血型不相容性ALDLT的围手术期管理,打破了ABO血型不相容的障碍。本综述重点关注手术技术的最新创新、安全的供体选择、通过扩大患者选择标准来扩大ALDLT的当前策略以及成功所需团队合作的重要方面。